Zimmer Biomet Holdings Inc (NYSE:ZBH), a leading player in the medical devices sector with a market capitalization of $22.12 ...
BTIG analyst Ryan Zimmerman has maintained their bullish stance on ZBH stock, giving a Buy rating on January 23.Invest with Confidence: Follow ...
Zimmer Biomet (NYSE:ZBH – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Needham & Company LLC in a research note issued to investors on Wednesday,Benzinga reports.
In a report released today, Caitlin Cronin from Canaccord Genuity maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), ...
Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire ...
Fifth Third Bancorp lessened its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 2.5% in the fourth ...
Zimmer Biomet (NYSE:ZBH) to acquire Paragon 28 (NYSE:FNA) for approximately $1.1B to expand its portfolio in the orthopedic surgical device market. Paragon 28 is Colorado-based medical device company ...
Paragon 28, Inc. (NYSE:FNA) shares are trading higher premarket on Wednesday. On Tuesday, the company inked a deal to be ...
Zimmer Biomet Holdings Inc. closed 15.92% short of its 52-week high of $133.90, which the company achieved on March 28th.
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, Inc. (NYSE: FNA), a leading medical device company focused exclusively on the foot and ankle ...
JP Morgan has recently raised Zimmer Biomet Holdings Inc (ZBH) stock to Overweight rating, as announced on December 17, 2024, according to Finviz. Earlier, on September 10, 2024, Wolfe Research had ...
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...